STD/HIV/UTI Vitals for May 2017

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

We screened 1166 studies on STD/HIV/UTI this month. These are the most important.

African-American MSM have 3-fold higher risk for young-onset prostate cancer

Source: Cancer Causes Control

  • Compared with non-African men who have sex with men, African American HIV-positive and HIV-negative men aged 40-55 y have 3-fold increased risk for young-onset prostate cancer.


  More details »


HIV: targeted testing tops universal screening in young sexual minority males

Source: JAMA Pediatr

  • Compared with universal screening, community-based targeted approaches to HIV testing are more effective in reaching young sexual minority males (especially of color), identifying new HIV-positive youths, and linking HIV-negative youths to preventive services.


  More details »


HIV PEP: once-daily dolutegravir + tenofovir/emtricitabine yields 90% completion rate

Source: JAMA Cardiol

  • Once-daily postexposure prophylaxis using dolutegravir with tenofovir disoproxil fumarate-emtricitabine appears safe and well-tolerated, with high adherence and completion rates in gay and bisexual men.

   More details »


Previous Vitals on STD/HIV/UTIApril '17March '17

Other recent Vitals: